Gohealth, Inc. · NASDAQ:GOCO

Gohealth — Q3 2024 Earnings Presentation

11 slides from Gohealth's earnings presentation, Nov 7, 2024

  1. Slide 1: Third Quarter 2024 Results

    Third Quarter 2024 Results November 7, 2024

  2. Slide 2: Forward-Looking Statements

    FORWARD-LOOKING STATEMENTS This earnings presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking

  3. Slide 3: Use of Non-GAAP Financial Measures and Key Performance Indicators

    USE OF NON-GAAP FINANCIAL MEASURES AND KEY PERFORMANCE INDICATORS Non-GAAP Financial Measures In this earnings presentation we use supplemental measures of our performance that are derived from our consolidated financial information, but which are not presented in our Condensed Consolidated Financia

  4. Slide 4: Reported Financial Comparison Year-over-Year

    Reported Financial Comparison Year-over-Year Revenue and Adjusted EBITDA comparisons for the third fiscal quarter Q ’ TO Q ’ 4 Q ’ TO Q ’ 4 REVENUE COMPARISON ($M)1 ADJ. EBITDA COMPARISON ($M)1,2 Q3 23 Q3 24 Q3 23 Q3 24 1. There may be slight differences compared to numbers shown in the Press Releas

  5. Slide 5: Cash Flow from Operations Year-to-Date and Trailing Twelve Months

    Cash Flow from Operations Year-to-Date (“YTD”) and Trailing Twelve Months (“TTM”) TTM Cash Flow is a liquidity measure that normalizes quarterly seasonality YTD CASH FLOW FROM OPERATIONS ($M)1 TTM CASH FLOW FROM OPERATIONS ($M)1 Q3 23 TD Q3 24 TD Q3 23 TTM Q3 24 TTM 1. There may be slight difference

  6. Slide 6: Medicare Unit Economics Year-over-Year

    Medicare Unit Economics Year-over-Year Continued improvements in efficiency and cost-effectiveness drive lower Direct Operating Cost per Submission. SALES PER SUBMISSION2 DIRECT OPERATING COST PER SUBMISSION3 UNIT ECONOMICS PER SUBMISSION ($’s in ones)1 Q ’ Q ’ 4 4 Q3 23 Q3 24 Q3 23 Q3 24 1. There m

  7. Slide 7: Appendix

    Appendix GoHealtht 7

  8. Slide 8: Appendix – TTM Financial Comparison Year-over-Year

    Appendix – TTM Financial Comparison Year-over-Year TTM Revenue and Adjusted EBITDA growth YoY Q ’ TTM TO Q ’ 4 TTM REPORTED REVENUE Q ’ TTM TO Q ’ 4 TTM REPORTED ADJ EBITDA COMPARISON ($M)1 COMPARISON ($M)1,2 4 Q3 23 TTM Q3 24 TTM Q3 23 TTM Q3 24 TTM 1. There may be slight differences compared to nu

  9. Slide 9: Appendix – Reconciliation of Net Income to Adjusted EBITDA

    Appendix – Reconciliation of Net Income to Adjusted EBITDA The following table sets forth the reconciliations of GAAP net income (loss) to EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin for the periods presented: Three months ended Sep. 30, Nine months ended Sep. 30, (in thousands)1 2024 2023 20

  10. Slide 10: Appendix – Reconciliation of Net Income to Adjusted EBITDA (TTM)

    Appendix – Reconciliation of Net Income to Adjusted EBITDA The following table sets forth the reconciliations of GAAP net income (loss) to EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin for the periods presented: TTM ended Sep. 30, (in thousands)1 2024 2023 Net revenues $686,459 $527,350 Net inc

  11. Slide 11: GoHealth.com

    GoHealth.com GoHealth.com | 222 W. Merchandise Mart Plaza, Chicago, IL 60654 | 1-855-493-3940 1-312-386-8200 Copyright © 2024 GoHealth. All Rights Reserved 11

GoHealth — Q3 2024 Earnings Presentation on 6ix